These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2431514)

  • 1. HLA-B POT: a new HLA-antigen within the B7-cross reactive group.
    Reekers P; van der Beucken M; Andrien M; Beelen J; Mueller-Eckhardt G; Schreuder GM
    Tissue Antigens; 1986 Sep; 28(3):182-9. PubMed ID: 2431514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of HLA-Bw73 by serology and one-dimensional isoelectric focusing patterns.
    Eynon EE; Yang SY; Cronin CR; Alosco SM; Alper CA; Yunis EJ
    Hum Immunol; 1986 Aug; 16(4):356-63. PubMed ID: 2428782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A reanalysis of the HLA-B7 cross-reactive group.
    Darke C
    Tissue Antigens; 1983 Nov; 22(5):326-34. PubMed ID: 6606863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The HLA-B12 and -B40 cross-reactive groups and their serological relationships.
    Darke C
    Tissue Antigens; 1983 Apr; 21(4):281-95. PubMed ID: 6190263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA antigens in Reiter's syndrome in Israeli patients.
    Ben-Chetrit E; Brautbar C; Rubinow A
    J Rheumatol; 1985 Oct; 12(5):964-6. PubMed ID: 3878883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of responder cell activity in mixed leukocyte culture reactions. I. Evidence of cross-reactivity of B7-antibody with HLA-B8.
    de Rooij-Doyer E; Bruning JW; van Rood JJ
    Tissue Antigens; 1981 Sep; 18(3):154-65. PubMed ID: 7336421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Public antigenic determinant on a family of HLA-B molecules.
    Schwartz BD; Luehrman LK; Rodey GE
    J Clin Invest; 1979 Oct; 64(4):938-47. PubMed ID: 90060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allelic segregation of HLA-Bw73 from B7.
    Rani R; Gill DK; Mittal KK
    Hum Hered; 1987; 37(4):201-4. PubMed ID: 3498679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-B SNA antigen: a BW6 associated B locus antigen belonging to the B5 CREG.
    Andrien M; Reekers P; Stordeur P; Vandercruys M; Dupont E
    Tissue Antigens; 1989 Mar; 33(3):400-7. PubMed ID: 2741166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A transposable epitope of HLA-B7, B40 molecules.
    Ways JP; Lawlor DA; Wan AM; Parham P
    Immunogenetics; 1987; 25(5):323-8. PubMed ID: 2437025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic determinants of the HLA-B7 molecule; Bw6- and B7-specific determinants are spatially separate.
    Parham P
    Immunogenetics; 1983; 18(1):1-16. PubMed ID: 6190743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of an HLA-Bw6-related specificity by the HLA-Cw3 molecule.
    Layet C; Delovitch T; Ferrier P; Caillol DH; Jordan BR; Lemonnier FA
    Immunogenetics; 1985; 21(5):469-78. PubMed ID: 2581891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in conformation with loss of alloantigenic determinants of a histocompatibility antigen (HLA-B7) induced by monoclonal antibodies.
    Parham P
    J Immunol; 1984 Jun; 132(6):2975-83. PubMed ID: 6202768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bw4-reactive and Bw6-reactive antibodies recognize multiple distinct HLA structures that partially overlap in the alpha-1 helix.
    Lutz CT; Smith KD; Greazel NS; Mace BE; Jensen DA; McCutcheon JA; Goeken NE
    J Immunol; 1994 Nov; 153(9):4099-110. PubMed ID: 7523516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The binding of monoclonal antibodies to cell surface molecules. Quantitative analysis of the reactions and cross-reactions of an antibody (MB40.3) with four HLA-B molecules.
    Parham P
    J Biol Chem; 1984 Nov; 259(21):13077-83. PubMed ID: 6333424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA antigens: rabbit antisera reacting with all A series or all B series specificities.
    Cresswell P; Ayres JL
    Eur J Immunol; 1976 Feb; 6(2):82-8. PubMed ID: 786698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inclusion of HLA-Bw42, Bw54 and Bw55 within the HLA-B14 cross-reactive group.
    Darke C
    Tissue Antigens; 1983 Mar; 21(3):246-53. PubMed ID: 6190262
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cross-reacting HLA-B alleles as genetic markers of HLA-B27 negative ankylosing spondylitis].
    Haberhauer G; Bröll H
    Z Rheumatol; 1986; 45(5):260-2. PubMed ID: 3492838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of responder cell activity in mixed leukocyte culture reactions. II. Influence of antibody binding and shedding properties within a B7-cross-reactivity group.
    de Rooij-Doyer E; Schoen MA; Bruning JW; van Rood JJ
    Tissue Antigens; 1981 Oct; 18(4):205-16. PubMed ID: 6178176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two cytotoxic human-human hybridoma antibodies to HLA: TrAH10 (anti A3.1) and TrAG2 (anti B7, Bw42).
    Hansen T; Bratlie A; Johansen B; Hannestad K
    Tissue Antigens; 1989 May; 33(5):520-30. PubMed ID: 2552610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.